Following patients under treatment for hyperprolactinemia

Area of Science:

• Endocrinology
• Neuroscience

Background:

• Hyperprolactinemia management is complex, influenced by pituitary lesion status (none, microadenoma, macroadenoma) and reproductive goals.
• Asymptomatic hyperprolactinemia may allow for expectant management with regular monitoring.

Purpose of the Study:

• To outline a structured approach to managing hyperprolactinemia.
• To differentiate treatment strategies based on patient-specific factors.

Main Methods:

• Categorization of patients based on pituitary lesion size and presence.
• Consideration of patient's desire for pregnancy in treatment planning.
• Utilizing dopamine agonists as a primary medical therapy.
• Identifying criteria for neurosurgical referral.

Main Results:

• Dopamine agonist therapy is effective for most hyperprolactinemia cases.
• Management strategies are tailored to lesion type and pregnancy intentions.
• Expectant management is an option for asymptomatic patients.
• Neurosurgical intervention is reserved for refractory macroadenomas with mass effect.

Conclusions:

• Personalized management plans are crucial for effective hyperprolactinemia treatment.
• Dopamine agonists represent a cornerstone of medical therapy.
• Careful consideration of reproductive status and lesion characteristics guides therapeutic decisions.